The post Amplify Files for First XRP Income ETF With Options Strategy appeared on BitcoinEthereumNews.com. Key Insights: Amplify has submitted the first XRP option income ETF with the SEC. The fund will use a covered-call strategy to generate monthly payouts. Unlike a spot ETF, it avoids custody risks by tracking XRP-linked instruments. Asset manager Amplify Investments has submitted a proposal to the US Securities and Exchange Commission (SEC) for launching the first XRP-based “option income” exchange-traded fund (ETF). The Illinois-based asset manager has filed to list the fund on the Cboe BZX Exchange. The fund aims to track XRP’s price and generate a regular income stream through a covered call options strategy. Simply put, it will layer a conservative income on top of crypto’s volatility, funding monthly payouts via option sales. Market observers note that crypto funds using derivatives have historically fared better with regulators than those holding digital assets directly. In fact, the filing arrives amid a wave of crypto ETF hopefuls and growing institutional interest in XRP following regulatory clarity in recent months. Amplify’s Proposes XRP Monthly Option Income ETF Amplify’s newly filed XRP Monthly Option Income ETF is designed to deliver both exposure to XRP and regular income via a covered-call strategy. In practice, the fund would track XRP’s price via XRP-linked instruments rather than holding the token outright, then systematically sell call options on those holdings to collect premium income. Each option cycle typically lasts a few weeks, after which the strategy will reset; a model that prioritizes steady income over maximizing price gains. According to the prospectus, at least 80% of the fund’s assets will be tied to the XRP price. The remaining 20% will sit in US Treasuries or cash for stability and collateral purposes. Since this ETF does not invest directly in XRP, it avoids some of the custody and regulatory hurdles that spot crypto funds face. The… The post Amplify Files for First XRP Income ETF With Options Strategy appeared on BitcoinEthereumNews.com. Key Insights: Amplify has submitted the first XRP option income ETF with the SEC. The fund will use a covered-call strategy to generate monthly payouts. Unlike a spot ETF, it avoids custody risks by tracking XRP-linked instruments. Asset manager Amplify Investments has submitted a proposal to the US Securities and Exchange Commission (SEC) for launching the first XRP-based “option income” exchange-traded fund (ETF). The Illinois-based asset manager has filed to list the fund on the Cboe BZX Exchange. The fund aims to track XRP’s price and generate a regular income stream through a covered call options strategy. Simply put, it will layer a conservative income on top of crypto’s volatility, funding monthly payouts via option sales. Market observers note that crypto funds using derivatives have historically fared better with regulators than those holding digital assets directly. In fact, the filing arrives amid a wave of crypto ETF hopefuls and growing institutional interest in XRP following regulatory clarity in recent months. Amplify’s Proposes XRP Monthly Option Income ETF Amplify’s newly filed XRP Monthly Option Income ETF is designed to deliver both exposure to XRP and regular income via a covered-call strategy. In practice, the fund would track XRP’s price via XRP-linked instruments rather than holding the token outright, then systematically sell call options on those holdings to collect premium income. Each option cycle typically lasts a few weeks, after which the strategy will reset; a model that prioritizes steady income over maximizing price gains. According to the prospectus, at least 80% of the fund’s assets will be tied to the XRP price. The remaining 20% will sit in US Treasuries or cash for stability and collateral purposes. Since this ETF does not invest directly in XRP, it avoids some of the custody and regulatory hurdles that spot crypto funds face. The…

Amplify Files for First XRP Income ETF With Options Strategy

Key Insights:

  • Amplify has submitted the first XRP option income ETF with the SEC.
  • The fund will use a covered-call strategy to generate monthly payouts.
  • Unlike a spot ETF, it avoids custody risks by tracking XRP-linked instruments.

Asset manager Amplify Investments has submitted a proposal to the US Securities and Exchange Commission (SEC) for launching the first XRP-based “option income” exchange-traded fund (ETF).

The Illinois-based asset manager has filed to list the fund on the Cboe BZX Exchange. The fund aims to track XRP’s price and generate a regular income stream through a covered call options strategy.

Simply put, it will layer a conservative income on top of crypto’s volatility, funding monthly payouts via option sales.

Market observers note that crypto funds using derivatives have historically fared better with regulators than those holding digital assets directly.

In fact, the filing arrives amid a wave of crypto ETF hopefuls and growing institutional interest in XRP following regulatory clarity in recent months.

Amplify’s Proposes XRP Monthly Option Income ETF

Amplify’s newly filed XRP Monthly Option Income ETF is designed to deliver both exposure to XRP and regular income via a covered-call strategy.

In practice, the fund would track XRP’s price via XRP-linked instruments rather than holding the token outright, then systematically sell call options on those holdings to collect premium income.

Each option cycle typically lasts a few weeks, after which the strategy will reset; a model that prioritizes steady income over maximizing price gains.

According to the prospectus, at least 80% of the fund’s assets will be tied to the XRP price. The remaining 20% will sit in US Treasuries or cash for stability and collateral purposes.

Since this ETF does not invest directly in XRP, it avoids some of the custody and regulatory hurdles that spot crypto funds face.

The SEC has yet to greenlight any spot XRP fund, even after Ripple’s partial courtroom victory clarified aspects of XRP’s legal status.

But the agency has shown comfort with derivatives-based crypto products in the past, as these operate within regulated commodities markets.

Meanwhile, corporate adoption of XRP has started to pick up pace, as Japanese gaming giant Gumi recently announced its plan to buy ¥2.5 billion worth of XRP.

Market commentators are highlighting the company’s strategy, stating that Gumi is stockpiling XRP for utility and Bitcoin as a treasury asset.

Why an XRP Income ETF Could Attract New Investors

For investors, the proposed fund opens a new avenue to gain exposure to XRP with an attached income stream.

By selling call options on its XRP positions, the fund would generate premiums that are paid out as distributions. This means that even if XRP’s price remains flat, investors could still receive a cash flow.

Crypto enthusiasts think that this feature could attract new investors who were previously hesitant. Many conservative portfolio managers can potentially consider diversifying into the new XRP product.

Similar covered-call funds have seen encouraging results in the Web3 space. For example, Bitcoin option-income ETFs launched in the past year and already have tens of millions in assets under management.

One Bitcoin high income ETF has attracted nearly $600 million in assets within its first year, highlighting the sheer demand for yield-focused crypto products.

Amplify’s XRP ETF could bring that formula to the world’s fourth-largest cryptocurrency. If approved, it would be the first real opportunity for investors to earn passive income on XRP via a US-regulated vehicle.

Source: https://www.thecoinrepublic.com/2025/09/01/amplify-files-for-first-xrp-income-etf-with-options-strategy/

Market Opportunity
Streamflow Logo
Streamflow Price(STREAM)
$0.01621
$0.01621$0.01621
-0.85%
USD
Streamflow (STREAM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23